Revatis US

Revatis AM is a Joint Venture Company between Revatis sa (Belgium) and Texas A&M System

Learn more


RevatisAM was founded in 2016 in collaboration with Texas A&M University and its growth is underpinned by its innovative and patented technology to obtain pluripotent adult Mesenchymal Stem Cells from a minimally invasive muscle micro-biopsy. The company’s fields of activity cover R&D, veterinary medicine and human medicine. For more information, do not hesitate to contact us and visit the website of the parent company.


Board of Directors

D. Serteyn

JP. Lacomble

J. Martial

B. Cornwell

J. Quintana

Advisory Council

Dr. S. McKenzie

A. Dayan

R. Whitaker

T. Evans